Dalao, Victor A.

HRN: 10-74-84  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/05/2022
CEFUROXIME 750MG (VIAL)
06/05/2022
06/12/2022
IV
700mg
Q8
Straddle Injury
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Urinary TractSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: